Page last updated: 2024-08-24

emtricitabine and Bone Diseases

emtricitabine has been researched along with Bone Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, PL; Bekker, LG; Buchbinder, SP; Chariyalertsak, S; Glidden, DV; Grant, RM; Grinsztejn, B; Guanira, J; McMahan, V; Mulligan, K; Schechter, M	1
Bedimo, R; Myers, J; Rosenblatt, L	1

Reviews

1 review(s) available for emtricitabine and Bone Diseases

Article	Year
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection. HIV clinical trials, 2016, Volume: 17, Issue:6 Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Diseases; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Emtricitabine; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir; Treatment Outcome	2016

Article

Year

Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection.

HIV clinical trials, 2016, Volume: 17, Issue:6

Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Diseases; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Emtricitabine; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir; Treatment Outcome

2016

Trials

1 trial(s) available for emtricitabine and Bone Diseases

Article	Year
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2 Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Emtricitabine; Female; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Male; Patient Compliance; Pre-Exposure Prophylaxis; Tenofovir	2017

Article

Year

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.

Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2

Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Emtricitabine; Female; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Male; Patient Compliance; Pre-Exposure Prophylaxis; Tenofovir

2017